| Model Number |
2102 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Myocardial Infarction (1969); Skin Inflammation/ Irritation (4545)
|
| Date of Event |
05/21/2021
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Interviews with the surgeon and cardiologist confirm that the patient's underlying cardiac condition and history along with the anesthesia regimen likely resulted in the nstemi and mi is an identified inherent risk associated with the use of the system.These interviews also confirmed that a desire to restart anticoagulant therapy soon after the implant procedure resulted in the prolonged hospitalization to monitor the swelling in the patient's neck prior to release.Both concerns were reported to have completely resolved.
|
| |
|
Event or Problem Description
|
|
Patient was implanted on (b)(6) 2021 with the barostim neo system.On or about (b)(6) 2021 the patient experienced a non-st segment elevation myocardial infarction (nstemi) which was managed with nitroglycerin and did not require catheterization.The surgeon and cardiologist attributed this to the anesthesia regimen for the implant procedure.The patient was reported to have an extensive cardiac history including past nstemi events.Patient was hospitalized until (b)(6) 2021 but not due to the nstemi.This was reportedly due to additional swelling at the neck incision site related to restarting of anticoagulation therapy soon after the procedure.All events were reportedly addressed and felt to resolve quickly with medical management on the floor and did not require additional invasive procedures.Cvrx was not made aware of this event until (b)(6) 2021.
|
| |
|
Search Alerts/Recalls
|